S&P・Nasdaq 本質的価値 お問い合わせ

Envista Holdings Corp NVST NYSE

NYSE • Healthcare • Medical - Equipment & Services • US • USD

SharesGrow Score
43/100
0/7 Pass
SharesGrow Intrinsic Value
$19.72
-28%
Analyst Price Target
$27.22
-0.6%

合計 50 件の最近のインサイダー取引記録が記録されています Envista Holdings Corp (NVST), 内訳は 36 件の買い および 11 件の売り. インサイダー買い総額は $7.05M インサイダー売り総額は $3.39M.

最近活動のある主要インサイダーには Hammes Eric D., Keel Paul A, Nance Mark E. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.

インサイダー取引記録 — NVST

日付 氏名 役職 取引種別 株数 平均価格 価値 保有株数
2026-02-25 Hammes Eric D. Chief Financial Officer RSU 付与(制限付株式) 29,225 - - 29,225
2026-02-25 Keel Paul A Chief Executive Officer RSU 付与(制限付株式) 115,320 $29.59 $3.41M 115,320
2026-02-25 Nance Mark E General Counsel RSU 付与(制限付株式) 23,070 - - 23,070
2026-02-25 Reis Mischa SVP, Strategy & Bus. Dev. RSU 付与(制限付株式) 10,770 - - 10,770
2026-02-25 Kaabi Faez C Chief Accounting Officer RSU 源泉徴収 4,964 $29.59 $146.88K 45,032
2026-02-25 Befidi Robert President, Diagnostics RSU 付与(制限付株式) 13,845 - - 13,845
2026-02-25 Nilsson Stefan President, Nobel Biocare RSU 付与(制限付株式) 13,845 - - 13,845
2026-02-25 Acurio Veronica President, Orthodontics RSU 付与(制限付株式) 13,845 - - 13,845
2026-02-10 Reis Mischa SVP, Strategy & Bus. Dev. オプション行使(売却) 5,634 $15.97 $89.97K -
2026-02-01 Hammes Eric D. Chief Financial Officer RSU 付与(制限付株式) 1,119 - - 1,119
2026-02-01 Keel Paul A Chief Executive Officer RSU 付与(制限付株式) 4,091 - - 4,091
2026-02-01 Nance Mark E General Counsel RSU 付与(制限付株式) 2,006 - - 7,587
2026-02-01 Reis Mischa SVP, Strategy & Bus. Dev. RSU 付与(制限付株式) 2,919 - - 29,357
2026-02-01 Kaabi Faez C Chief Accounting Officer RSU 付与(制限付株式) 1,186 - - 5,040
2026-02-01 Befidi Robert President, Diagnostics RSU 付与(制限付株式) 998 - - 2,149
2026-02-01 Acurio Veronica President, Orthodontics RSU 付与(制限付株式) 998 - - 998
2025-11-01 Keel Paul A Chief Executive Officer RSU 源泉徴収 54,097 $20.35 $1.1M 347,555
2025-08-25 Hammes Eric D. Chief Financial Officer RSU 源泉徴収 7,654 $21.12 $161.65K 96,788
2025-08-25 Reis Mischa SVP, Strategy & Bus. Dev. 情報に基づく売り 15,000 $21.60 $324K 32,382
2025-08-25 Befidi Robert President, Diagnostics RSU 源泉徴収 3,454 $21.12 $72.95K 45,504
2025-08-25 Nilsson Stefan President, Nobel Biocare RSU 源泉徴収 804 $21.12 $16.98K 54,941
2025-08-25 Acurio Veronica President, Orthodontics RSU 源泉徴収 5,422 $21.12 $114.51K 50,323
2025-07-14 Pierce James Andrew Director 不明 - - - -
2025-07-14 Pierce James Andrew Director RSU 付与(制限付株式) 9,155 - - 9,155
2025-06-10 Tsingos Christine A Director RSU 付与(制限付株式) 10,450 - - 50,600
2025-06-10 Raskas Daniel Director RSU 付与(制限付株式) 10,450 - - 44,680
2025-06-10 Gallahue Kieran Director RSU 付与(制限付株式) 10,450 - - 44,680
2025-06-10 Huennekens R Scott Director RSU 付与(制限付株式) 14,370 - - 69,520
2025-06-10 Jain Vivek Director RSU 付与(制限付株式) 10,450 - - 43,615
2025-06-10 Carruthers Wendy Director RSU 付与(制限付株式) 10,450 - - 50,610
2025-06-10 Hulit Barbara B. Director RSU 付与(制限付株式) 10,450 - - 79,820
2025-05-25 Keel Paul A Chief Executive Officer RSU 源泉徴収 12,787 $16.72 $213.8K 401,652
2025-02-26 Reis Mischa SVP, Strategy & Bus. Dev. RSU 付与(制限付株式) 8,475 - - 47,382
2025-02-25 Hammes Eric D. Chief Financial Officer RSU 付与(制限付株式) 28,995 - - 28,995
2025-02-25 Keel Paul A Chief Executive Officer RSU 付与(制限付株式) 153,660 $20.66 $3.17M 153,660
2025-02-25 Nance Mark E General Counsel RSU 付与(制限付株式) 33,455 - - 33,455
2025-02-25 Reis Mischa SVP, Strategy & Bus. Dev. RSU 付与(制限付株式) 15,615 - - 15,615
2025-02-25 Kaabi Faez C Chief Accounting Officer RSU 付与(制限付株式) 22,600 $20.66 $466.92K 22,600
2025-02-25 Befidi Robert President, Diagnostics RSU 付与(制限付株式) 18,960 - - 18,960
2025-02-25 Nilsson Stefan President, Nobel Biocare RSU 付与(制限付株式) 18,960 - - 18,960
2025-02-25 Acurio Veronica President, Orthodontics RSU 付与(制限付株式) 18,960 - - 18,960
2025-02-01 Nance Mark E General Counsel RSU 付与(制限付株式) 965 - - 5,581
2025-02-01 Reis Mischa SVP, Strategy & Bus. Dev. RSU 付与(制限付株式) 3,152 - - 26,438
2025-02-01 Kaabi Faez C Chief Accounting Officer RSU 付与(制限付株式) 689 - - 3,854
2025-02-01 Befidi Robert President, Diagnostics RSU 付与(制限付株式) 1,151 - - 1,151
2024-11-18 Nilsson Stefan President, Nobel Biocare 不明 - - - 45,455
2024-11-18 Acurio Veronica President, Orthodontics 不明 - - - 45,455
2024-11-01 Keel Paul A Chief Executive Officer RSU 源泉徴収 53,996 $20.94 $1.13M 348,609
2024-09-17 Reis Mischa SVP, Strategy & Bus. Dev. RSU 源泉徴収 812 $19.00 $15.43K 42,720
2024-08-25 Hammes Eric D. Chief Financial Officer RSU 付与(制限付株式) 64,175 - - 88,707
情報付き — 公開市場取引(最も重要) 情報なし(買い) — 報酬・オプション行使・転換 情報なし(売り) — 源泉徴収・付与売却 中立 — 贈与・信託・失効
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る